Help us to review health, safety and social services
Welcome
There's much to see here. So, take your time, look around, and learn all there is to know about us. We hope you enjoy our site and take a moment to drop us a line.
Important information
Mental Health Report: Women at Work
This is a great opportunity for partnership/ collaboration and we will strive to get community voices to discuss the stresses of work life balances.
Join us on how to influence policy and how it impacts the BAME community, not excluding others.
Contact Us at info@bamehealthcollaborative.org
Tobacco: treating dependence quality standard (QS207)
This quality standard covers support and treatment to stop smoking and stop using smokeless tobacco, and harm-reduction approaches for people who are not ready to stop in one go. It describes high-quality care in priority areas for improvement.
Consultations with NICE
NICE guideline on Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and m
NICE guideline on Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and m
Revised approach to updating technology appraisal recommendations for COVID-19 medicines
- Part 1: Modular update to the health technology evaluation process manual
- Part 2: Revised approach to updating technology appraisal recommendations for COVID-19 medicines
Deadline 25th July 2023
Contact Us at info@bamehealthcollaborative.org
NICE guideline on Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and m
NICE guideline on Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and m
NICE guideline on Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and m
This guideline update will make recommendations for babies up to and including 28 days old only when the population is not already covered by other NICE guidelines, such as the NICE guideline on neonatal infection: antibiotics for prevention and treatment (NG195).
The consultation on the draft guideline and its supporting evidence is due to start on 03/08/23 and it will run for 6 weeks, closing on 15/09/23